Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Emerald Health Therapeutics Inc (OP: EMHTF ) N/A UNCHANGED Last Price Updated: 3:42 PM EST, Nov 11, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.0405 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Emerald Health Therapeutics and Skye Bioscience Close Plan of Arrangement November 10, 2022 Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the... Via Newsfile Topics Cannabis Exposures Cannabis Emerald Health Therapeutics Announces Bridge Loan to Skye Bioscience and Provides Update on Merger October 18, 2022 Vancouver, British Columbia--(Newsfile Corp. - October 18, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the... Via Newsfile Performance More News Read More Skye Bioscience Stockholders Vote in Favor of Arrangement Agreement with Emerald Health Therapeutics, Inc. September 30, 2022 Via Newsfile Topics Derivatives Exposures Derivatives The Canadian Cannabis Report - Monday, Sept. 12 September 12, 2022 Via Talk Markets Emerald Health Therapeutics, Inc. Reports 2022 Q2 Results August 31, 2022 Via Newsfile Emerald Health Therapeutics Receives Court Approval of Plan of Arrangement with Skye Bioscience August 26, 2022 Via Newsfile HYTN Awarded Medical Cannabis Sales License By Health Canada August 23, 2022 Via Benzinga Emerald Health Therapeutics Shareholders Vote in Favour of Plan of Arrangement with Skye Bioscience August 19, 2022 Via Newsfile Topics Regulatory Compliance Exposures Legal Regulatory Emerald Health Therapeutics, Inc. Reports 2022 Q1 Results July 11, 2022 Via Newsfile Topics Cannabis Exposures Cannabis The Canadian Cannabis Report - Monday, July 4 July 04, 2022 Via Talk Markets Emerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Update July 04, 2022 Via Newsfile Topics Cannabis Exposures Cannabis The Canadian Cannabis Report - Monday, June 20 June 20, 2022 Via Talk Markets Skye Bioscience Signs Arrangement Agreement With Emerald Health Therapeutics, Here Are The Details May 12, 2022 Via Benzinga Emerald Health Therapeutics Signs Arrangement Agreement with Skye Bioscience May 12, 2022 Via Newsfile Topics Derivatives Exposures Derivatives The Canadian Cannabis Report - Monday, March 28 March 28, 2022 Via Talk Markets HYTN Innovations To Accept Cannabis Orders Directly From Provinces & Territories March 17, 2022 Via Benzinga The Canadian Cannabis Report - Monday, Mar. 7 March 07, 2022 Via Talk Markets HYTN Innovations Receives Health Canada's Approval To Sell Cannabis February 22, 2022 Via Benzinga Emerald Health Therapeutics Sells Patents to FlowerPod January 11, 2022 Via Newsfile Topics Cannabis Intellectual Property Exposures Cannabis Intellectual Property The Canadian Cannabis Report - Monday, Jan. 3 January 03, 2022 Via Talk Markets The Canadian Cannabis Report- Monday, Dec. 27 December 27, 2021 Via Talk Markets The Canadian Cannabis Report- Monday, Dec. 20 December 20, 2021 Via Talk Markets Emerald Health Therapeutics Leaving 'Saturated' Cannabis Market, Will Focus On Pharmaceuticals November 29, 2021 Via Benzinga Topics Cannabis Exposures Cannabis Emerald Health Therapeutics Pivots Out of Recreational and Medical Cannabis and into Pharmaceutical Development November 29, 2021 Via Newsfile Topics Cannabis Exposures COVID-19 Cannabis The Canadian Cannabis Report: There Were No Stocks That Increased By More Than 10% November 23, 2021 Via Talk Markets Topics Cannabis Exposures Cannabis Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.